Literature DB >> 27578439

Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

M L Boisen1,2,3, J N Hartnett2, A Goba4,5, M A Vandi4,5, D S Grant4,5, J S Schieffelin6, R F Garry2,3, L M Branco3.   

Abstract

The 2013-16 West African Ebola outbreak is the largest, most geographically dispersed, and deadliest on record, with 28,616 suspected cases and 11,310 deaths recorded to date in Guinea, Liberia, and Sierra Leone. We provide a review of the epidemiology and management of the 2013-16 Ebola outbreak in West Africa aimed at stimulating reflection on lessons learned that may improve the response to the next international health crisis caused by a pathogen that emerges in a region of the world with a severely limited health care infrastructure. Surveillance efforts employing rapid and effective point-of-care diagnostics designed for environments that lack advanced laboratory infrastructure will greatly aid in early detection and containment efforts during future outbreaks. Introduction of effective therapeutics and vaccines against Ebola into the public health system and the biodefense armamentarium is of the highest priority if future outbreaks are to be adequately managed and contained in a timely manner.

Entities:  

Keywords:  Ebola virus; epidemiology; filoviruses; outbreak management; point-of-care testing; viral diagnostics; viral genetics; viral therapeutics; viral vaccines

Mesh:

Substances:

Year:  2016        PMID: 27578439      PMCID: PMC7297506          DOI: 10.1146/annurev-virology-110615-040056

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  116 in total

1.  Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.

Authors:  H Ito; S Watanabe; A Takada; Y Kawaoka
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease.

Authors:  Diana F Florescu; Andre C Kalil; Angela L Hewlett; Amy J Schuh; Ute Stroher; Timothy M Uyeki; Philip W Smith
Journal:  Clin Infect Dis       Date:  2015-05-19       Impact factor: 9.079

3.  Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008.

Authors:  Gilda Grard; Roman Biek; Jean-Jacques Muyembe Tamfum; Joseph Fair; Nathan Wolfe; Pierre Formenty; Janusz Paweska; Eric Leroy
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.

Authors:  Emily P Thi; Chad E Mire; Raul Ursic-Bedoya; Joan B Geisbert; Amy C H Lee; Krystle N Agans; Marjorie Robbins; Daniel J Deer; Karla A Fenton; Ian MacLachlan; Thomas W Geisbert
Journal:  Sci Transl Med       Date:  2014-08-20       Impact factor: 17.956

5.  Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.

Authors:  Natarajan Ayithan; Steven B Bradfute; Scott M Anthony; Kelly S Stuthman; John M Dye; Sina Bavari; Mike Bray; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2013-10-08       Impact factor: 2.607

6.  Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.

Authors:  N Jaax; P Jahrling; T Geisbert; J Geisbert; K Steele; K McKee; D Nagley; E Johnson; G Jaax; C Peters
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

Review 7.  Intracellular events and cell fate in filovirus infection.

Authors:  Judith Olejnik; Elena Ryabchikova; Ronald B Corley; Elke Mühlberger
Journal:  Viruses       Date:  2011-08       Impact factor: 5.048

8.  Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection.

Authors:  Natarajan Ayithan; Steven B Bradfute; Scott M Anthony; Kelly S Stuthman; Sina Bavari; Mike Bray; Keiko Ozato
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

9.  Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa.

Authors:  Miles W Carroll; David A Matthews; Julian A Hiscox; Michael J Elmore; Georgios Pollakis; Andrew Rambaut; Roger Hewson; Isabel García-Dorival; Joseph Akoi Bore; Raymond Koundouno; Saïd Abdellati; Babak Afrough; John Aiyepada; Patience Akhilomen; Danny Asogun; Barry Atkinson; Marlis Badusche; Amadou Bah; Simon Bate; Jan Baumann; Dirk Becker; Beate Becker-Ziaja; Anne Bocquin; Benny Borremans; Andrew Bosworth; Jan Peter Boettcher; Angela Cannas; Fabrizio Carletti; Concetta Castilletti; Simon Clark; Francesca Colavita; Sandra Diederich; Adomeh Donatus; Sophie Duraffour; Deborah Ehichioya; Heinz Ellerbrok; Maria Dolores Fernandez-Garcia; Alexandra Fizet; Erna Fleischmann; Sophie Gryseels; Antje Hermelink; Julia Hinzmann; Ute Hopf-Guevara; Yemisi Ighodalo; Lisa Jameson; Anne Kelterbaum; Zoltan Kis; Stefan Kloth; Claudia Kohl; Miša Korva; Annette Kraus; Eeva Kuisma; Andreas Kurth; Britta Liedigk; Christopher H Logue; Anja Lüdtke; Piet Maes; James McCowen; Stéphane Mély; Marc Mertens; Silvia Meschi; Benjamin Meyer; Janine Michel; Peter Molkenthin; César Muñoz-Fontela; Doreen Muth; Edmund N C Newman; Didier Ngabo; Lisa Oestereich; Jennifer Okosun; Thomas Olokor; Racheal Omiunu; Emmanuel Omomoh; Elisa Pallasch; Bernadett Pályi; Jasmine Portmann; Thomas Pottage; Catherine Pratt; Simone Priesnitz; Serena Quartu; Julie Rappe; Johanna Repits; Martin Richter; Martin Rudolf; Andreas Sachse; Kristina Maria Schmidt; Gordian Schudt; Thomas Strecker; Ruth Thom; Stephen Thomas; Ekaete Tobin; Howard Tolley; Jochen Trautner; Tine Vermoesen; Inês Vitoriano; Matthias Wagner; Svenja Wolff; Constanze Yue; Maria Rosaria Capobianchi; Birte Kretschmer; Yper Hall; John G Kenny; Natasha Y Rickett; Gytis Dudas; Cordelia E M Coltart; Romy Kerber; Damien Steer; Callum Wright; Francis Senyah; Sakoba Keita; Patrick Drury; Boubacar Diallo; Hilde de Clerck; Michel Van Herp; Armand Sprecher; Alexis Traore; Mandiou Diakite; Mandy Kader Konde; Lamine Koivogui; N'Faly Magassouba; Tatjana Avšič-Županc; Andreas Nitsche; Marc Strasser; Giuseppe Ippolito; Stephan Becker; Kilian Stoecker; Martin Gabriel; Hervé Raoul; Antonino Di Caro; Roman Wölfel; Pierre Formenty; Stephan Günther
Journal:  Nature       Date:  2015-06-17       Impact factor: 49.962

10.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962

View more
  8 in total

1.  The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab.

Authors:  Malwina J Radwańska; Mateusz Jaskółowski; Elena Davydova; Urszula Derewenda; Tsuyoshi Miyake; Daniel A Engel; Anthony A Kossiakoff; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-06-27       Impact factor: 7.652

2.  Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.

Authors:  Mohamed F Jalloh; Mohammad B Jalloh; Alison Albert; Brent Wolff; Amy Callis; Aparna Ramakrishnan; Emily Cramer; Paul Sengeh; Samuel Abu Pratt; Lansana Conteh; Rana Hajjeh; Rebecca Bunnell; John T Redd; Anna Mia Ekström; Helena Nordenstedt
Journal:  Vaccine       Date:  2019-02-10       Impact factor: 3.641

3.  Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa.

Authors:  Saori Sakabe; Brian M Sullivan; Jessica N Hartnett; Refugio Robles-Sikisaka; Karthik Gangavarapu; Beatrice Cubitt; Brian C Ware; Dylan Kotliar; Luis M Branco; Augustine Goba; Mambu Momoh; John Demby Sandi; Lansana Kanneh; Donald S Grant; Robert F Garry; Kristian G Andersen; Juan Carlos de la Torre; Pardis C Sabeti; John S Schieffelin; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

4.  Flex-nucleoside analogues - Novel therapeutics against filoviruses.

Authors:  Mary K Yates; Mithun R Raje; Payel Chatterjee; Christina F Spiropoulou; Sina Bavari; Mike Flint; Veronica Soloveva; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem Lett       Date:  2017-04-22       Impact factor: 2.823

5.  Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers.

Authors:  Trevor V Gale; Timothy M Horton; Donald S Grant; Robert F Garry
Journal:  PLoS Negl Trop Dis       Date:  2017-09-18

6.  Introduction to Special Issue of Plant Virus Emergence.

Authors:  Michael Goodin; Jeanmarie Verchot
Journal:  Viruses       Date:  2021-01-01       Impact factor: 5.048

7.  Evaluation of viral haemorrhagic fever surveillance system with focus on Ebola virus disease, Bawku municipality- Upper East Region, Ghana, 2011-2015.

Authors:  Francis Broni; Joseph O Larbi; Edwin A Afari; Kofi M Nyarko; Donne K Ameme; Ernest Kenu
Journal:  Ghana Med J       Date:  2020-06

8.  Engaging religious leaders to promote safe burial practices during the 2014-2016 Ebola virus disease outbreak, Sierra Leone.

Authors:  Padraig Lyons; Maike Winters; Zangin Zeebari; Kirsten Schmidt-Hellerau; Paul Sengeh; Mohammad B Jalloh; Mohamed F Jalloh; Helena Nordenstedt
Journal:  Bull World Health Organ       Date:  2021-03-02       Impact factor: 9.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.